Bio Protocol vs Huma Finance — how do they compare? Bio Protocol trades at Rp442.33 (market cap Rp993,55M, Rp177,92M 24h volume), while Huma Finance trades at Rp351.95 (market cap Rp1,15T, Rp73,62M 24h volume). The key difference: Huma Finance is far larger — about 1157.5× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 3,3B / 10B HUMA (33%) for Huma Finance. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Huma Finance for 14 Days on average.
| BIO | HUMA | |
|---|---|---|
Market Cap | Rp993,55M | Rp1,15T |
Volume (24h) | Rp177,92M | Rp73,62M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 3,3B / 10B HUMA (33%) |
Typical Hold Time | 17 Days | 14 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
HUMA is currently trading at Rp356.17 with a market cap of Rp1.16T, showing bearish technical signals with 16 sell signals versus 4 buy signals. The token faces resistance at Rp359 and finds support at Rp342, with oscillators in neutral territory. With only 33% of the 10M max supply in circulation and an average hold time of 14 days, the token shows moderate distribution but limited network activity.
Overall outlook remains cautious due to bearish technical indicators and limited fundamental developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks include high volatility, low liquidity, and regulatory uncertainty in the crypto space. Investors should monitor support levels closely.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Huma Finance is the first PayFi network that provides global payment financing with instant, on-demand liquidity—available anytime and anywhere. It enables payment institutions around the world to settle transactions 24/7 using stablecoins and on-chain liquidity. Huma supports a wide variety of PayFi use cases, including cross-border payments, credit card settlements, and trade finance, while also facilitating emerging solutions such as decentralized physical infrastructure network (DePIN) financing.
Read more on HUMA →